Accessibility Menu

Renalytix Plc(OTC) RNLXY

Market Cap$16.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-99%
5 Year-100%
1 Year-58%
1 Month+12%
$1.90
-0.76%
-0.01Today
Renalytix Plc last closing stock price
MetricPriceDate
Last closeUSD 1.902026-07-31
Renalytix Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 1.902026-07-24
1 month+11.76%USD 1.702026-07-01
3 month+58.33%USD 1.202026-05-01
Year to date-47.51%USD 3.622025-12-31
1 year-58.36%USD 4.562025-07-31
3 year-97.35%USD 71.752023-08-01
5 year-99.75%USD 751.252021-07-30
Since inception-99.43%USD 337.502020-07-17

Renalytix Plc Financials at a Glance

Market Cap

$16.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.25

Net Income (TTM)

-$8.62

EPS (TTM)

$0.00

P/E Ratio

-0.21

Dividend

$0.00

Beta (Volatility)

0.61 (Low)

Price

$1.90

Volume

302

Open

$1.90

Previous Close

$1.90

Daily Range

$1.90 - $1.90

52-Week Range

$1.00 - $8.09

Estimated Earnings Date

N/A

RNLXY News

happy-investors-checking-holdings

3 Great Stocks You Can Buy With $50 Right Now

Cory RenauerOct 20, 2021
investment-advisor-picking-stocks-with-clients

3 Growth Stocks Wall Street Thinks Could Rise 50% or More

Cory RenauerOct 7, 2021
three-scientists-laboratory-getty

3 High-Growth Healthcare Stocks to Buy in September

Cory RenauerSep 9, 2021
Getty-Images-Well-Protected-Scientist

3 High-Growth Healthcare Stocks to Buy in August

Cory RenauerAug 3, 2021
investors-picking-high-growth-stocks

3 High-Growth Stocks Truly Headed for the Moon

Cory RenauerJul 16, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Renalytix Plc

Renalytix Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.

Industry

Health Care Technology

Sector

Health Care

Employees

46

CEO

James Renwick McCullough, MBA

Website

renalytix.com

RNLXY Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-4.76%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$16.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.74M

Volume

302

Avg. Volume

3.74K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Renalytix Plc Performance Analysis

Renalytix Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 2,959,589N/A
20232023-06-30USD 3,415,70215.4%
20242024-06-30USD 2,301,930-32.6%
20252025-06-30USD 3,013,87430.9%
Renalytix Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD -30.96N/A
20232023-06-30USD -27.84-10.1%
20242024-06-30USD -21.05-24.4%
20252025-06-30USD -3.73-82.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$0.72

N/A

Gross Profit

$0.39

N/A

Gross Margin

54.60%

N/A

Market Cap

$16.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-$3.85

N/A

EBITDA

-$4.35

N/A

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Total Cash

$17.41

N/A

Total Debt

$8.21

N/A

Accounts Receivable

$0.51

N/A

Inventory

$0.42

N/A

Long Term Debt

$8.21

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-206.39%

N/A

Return on Invested Capital

81.36%

N/A

Free Cash Flow

-$9.97

N/A

Operating Cash Flow

-$9.97

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,485.58+0.01%
^DJIDJI
$52,526.13+0.01%
^IXICNASDAQ
$25,334.92+0.01%
BTCBitcoin
$63,012.00-0.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About RNLXY

What is the current price of Renalytix Plc?

Renalytix Plc is trading at $1.90 per share.

What is the 52-week range for Renalytix Plc?

Over the past 52 weeks, Renalytix Plc has traded between $1.00 and $8.09.

How much debt does Renalytix Plc have?

As of the most recent reporting period, Renalytix Plc reported total debt of $8.21M.

How much cash does Renalytix Plc have on hand?

Renalytix Plc reported $9.21M in cash and cash equivalents in its most recent financial results.

What is Renalytix Plc’s dividend yield?

Renalytix Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services